New hope for rare muscle diseases: dazukibart shows promise in Long-Term trial

NCT ID NCT06698796

Recruiting now Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Mar 19, 2026 · Last updated May 16, 2026 · Updated 11 times

Summary

This study looks at the long-term safety and effectiveness of a medicine called dazukibart for people with dermatomyositis or polymyositis, which are rare diseases that cause muscle weakness and inflammation. About 211 adults who were in a previous dazukibart study will receive the drug as an IV infusion every 4 weeks for about a year, then be followed for safety. The goal is to see if dazukibart can help control the disease over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Glendale
RECRUITING

Glendale, Arizona, 85306, United States
Anhui Provincial Hospital
RECRUITING

Hefei, Anhui, 230071, China
Arthritis & Rheumatology Research Institute, PLLC
NOT_YET_RECRUITING

Allen, Texas, 75013, United States
CHARM HEALTHCARE PRIVATE LIMITED (Previously Dr Shenoy's Care Private Limited)
RECRUITING

Ernākulam, Kerala, 682040, India
Centro de Investigaciones Médicas Tucuman
RECRUITING

SAN M. de Tucuman, Tucumán Province, T4000AXL, Argentina
Chi Mei Medical Center
NOT_YET_RECRUITING

Tainan, 71004, Taiwan
Cryptex Investigación Clínica S.A. de C.V.
RECRUITING

Cuauhtémoc, Mexico City, 06100, Mexico
Debreceni Egyetem Klinikai Kozpont
RECRUITING

Debrecen, 4032, Hungary
First Affiliated Hospital of Kunming Medical University
RECRUITING

Kunming, Yunnan, 650032, China
Hacettepe Universite Hastaneleri
RECRUITING

Altindağ, Ankara, 06230, Turkey (Türkiye)
Institute of Science Tokyo Hospital
RECRUITING

Bunkyo-ku, Tokyo, 113-8519, Japan
Medical Center Artmed
RECRUITING

Plovdiv, 4000, Bulgaria
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji
NOT_YET_RECRUITING

Warsaw, Masovian Voivodeship, 02-637, Poland
National Taiwan University Hospital
NOT_YET_RECRUITING

Taipei, 10002, Taiwan
Nerve & Muscle Center of Texas
RECRUITING

Houston, Texas, 77030, United States
Nippon Medical School Hospital
RECRUITING

Bunkyo-ku, Tokyo, 113-8603, Japan
Nova Reuma Domyslawska i Rusilowicz Spolka Partnerska Lekarza Reumatologa i Fizjoterapeuty
RECRUITING

Bialystok, Podlaskie Voivodeship, 15-707, Poland
Peking Union Medical College Hospital
RECRUITING

Beijing, 100730, China
Renji Hospital Shanghai Jiao Tong University School of Medicine
RECRUITING

Shanghai, Shanghai Municipality, 200001, China
Renji Hospital Shanghai Jiao Tong University School of Medicine
RECRUITING

Shanghai, Shanghai Municipality, 200127, China
Rheumatology & Pulmonary Clinic
RECRUITING

Beckley, West Virginia, 25801, United States
Sheba Medical Center
RECRUITING

Ramat Gan, Central District, 5262100, Israel
The Second Affiliated Hospital of Nanchang University
RECRUITING

Nanchang, Jiangxi, 330006, China
The Second Affiliated Hospital of Nanchang University
RECRUITING

Nanchang, Jiangxi, 330036, China

Conditions

Explore the condition pages connected to this study.

DERMATOMYOSITIS POLYMYOSITIS